Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

The intelligence a $25K terminal charges for — the day it breaks, in your market, at a fraction of the price.

The funding market, moving in real timeBook a DemoChoose your plan
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Executive ChangeItem 5.02 · 8-KLOW RiskNeutral

CONMED CORPORATION

www.conmed.com
Filed: Mar 13, 2026CIK: 0000816956Health Care
Watch CompanyView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

CONMED Corporation appointed Andrew Moller as Interim Principal Financial Officer effective March 15, 2026, promoting him from his role as Vice President and Corporate Controller. This leadership transition signals potential changes in financial strategy and brings substantial accounting expertise to the CFO position.

Key Takeaways

Andrew Moller promoted to Interim Principal Financial Officer effective March 15, 2026, after joining CONMED in January 2025 as Vice President and Corporate Controller

Moller brings significant financial leadership experience from Smith & Nephew (Global Controller and CFO Asia-Pacific) and Stanley Black & Decker (Director of Internal Audit)

2 more takeaways

Filing Overview

Form Type8-K
Filing DateMar 13, 2026
Item5.02
CategoryExecutive Change
CIK0000816956
Accession #001-39218
Risk LevelLOW
SentimentNeutral
Signalinformational
Topics
leadership transitionexecutive hire

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings